Page last updated: 2024-11-02

pargyline and Psychoses, Drug

pargyline has been researched along with Psychoses, Drug in 4 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SUTNICK, AI1
WEISS, LB1
SCHINDLER, PD1
SOLOFF, LA1
MCCURDY, RL1
KAN, FJ1
Shopsin, B1
Kline, NS1
Price, J1
Hopkinson, G1

Reviews

1 review available for pargyline and Psychoses, Drug

ArticleYear
Mono-amine oxidase inhibitors and schizophrenia.
    Psychiatria clinica, 1968, Volume: 1, Issue:2

    Topics: Acute Disease; Amines; Amphetamine; Chronic Disease; Hallucinogens; Humans; Iproniazid; Isoniazid; M

1968

Other Studies

3 other studies available for pargyline and Psychoses, Drug

ArticleYear
PSYCHOTIC REACTIONS DURING THERAPY WITH PARGYLINE.
    JAMA, 1964, May-11, Volume: 188

    Topics: Aged; Antihypertensive Agents; Geriatrics; Humans; Hypotension; Hypotension, Orthostatic; Monoamine

1964
TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE-IMIPRAMINE TREATMENT.
    The American journal of psychiatry, 1964, Volume: 121

    Topics: Brain; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Hypertension; Imipramine; Mental D

1964
Monoamine oxidase inhibitors: potential for drug abuse.
    Biological psychiatry, 1976, Volume: 11, Issue:4

    Topics: Amphetamines; Drug Tolerance; Feeding Behavior; Humans; Imipramine; Male; Middle Aged; Monoamine Oxi

1976